Survived
|
Blood glucose (mmol/l; median [range])
|
7.3 (6.6–14.8)*
|
8.7 (8.1–18.1)
|
|
Blood glucose < lower limit (n [%])
|
81/85 (95%)
|
89/92 (97%)
|
|
Episodes (median [range])
|
17 (2–75)*
|
8.5 (1–85)
|
|
Time point of occurrence (%)
| | |
|
Week 1
|
55%
|
50%
|
|
Week 2
|
24%
|
27%
|
|
Week 3
|
21%
|
23%
|
Died
|
Blood glucose (mmol/l; median [range])
|
2.7 (0.6–3.4); NS
|
3.7 (3.1–3.9)
|
|
Blood glucose < lower limit (n [%])
|
28/29 (97%)
|
20/22 (91%)
|
|
Episodes (median [range])
|
11.5 (1–31)*
|
6.5 (1–61)
|
|
Time point of occurrence (%)
| | |
|
Week 1
|
78%*
|
47%
|
|
Week 2
|
16%
|
18%
|
|
Week 3
|
6%
|
35%
|